Eisai Innovation
Profile and leaders
Eisai Innovation is the corporate venture arm of Eisai, a pharmaceutical and biotech company. It was founded in 2019 and is based in Cambridge, United States. It invests from pre-seed to seed. Sectors it names: biotech and life sciences, healthcare and digital health.
Every figure links to its source
Snapshot
Data behind this graphic
| Item | Value |
|---|---|
| Stage range | Pre-seed to Seed |
| Sectors | Biotech and life sciences, Healthcare and digital health |
| Geography | Global |
| Offices | Cambridge, United States |
Sources: S5 Lifespan Vision Ventures: Sift Biosciences USD 3.7M pre-seed (2026-02-18); S1 Eisai Innovation.
Where it invests and who leads it
LeadersS2S1
- Hidekazu IshidaCorporate Venture Capitalist, Head of CVI OfficeFind on LinkedInFirm page
- Yoshiharu MizuiPresident of Eisai Innovation IncFind on LinkedInFirm page
- Ryutaro AdachiManaging DirectorFind on LinkedInFirm page
- Paul WuInvestment DirectorFind on LinkedInFirm page
Key facts
Official pages
Read the firm's own pages for current information.
- Website www.eisaiinnovation.com/
Sources
- S1Eisai InnovationFirm
- S2Eisai: Corporate Venture CapitalParent company
- S3Eisai Group Worldwide (Eisai Innovation, Inc. address, Cambridge MA)Parent company
- S4Eisai release: Eisai Innovation selected for AMED program (2024)Firm
- S5Lifespan Vision Ventures: Sift Biosciences USD 3.7M pre-seed (2026-02-18)Portfolio company
- S6Business Wire: Excalipoint Therapeutics USD 68.7M seed financing (2026-03-18)Portfolio company
Disclaimer and corrections
Not affiliated. This page is not affiliated with, endorsed by or sponsored by Eisai Innovation or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.
Spotted a mistake? Report a correction.